A hot mess: A case of hyperemesis

Canadian Family Physician

Volumn 60, Issue 7, 2014, Pages 633-637

  Cheung, Eileen ^a   Ng, Carly ^a   Foote, John ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BATH; CANNABIS ADDICTION; CASE REPORT; COMPLICATION; HEAT; HUMAN; MALE; NAUSEA; SYNDROME; THERAPEUTIC USE; VOMITING;

ADULT; BATHS; HOT TEMPERATURE; HUMANS; MALE; MARIJUANA ABUSE; NAUSEA; SYNDROME; VOMITING;

EID: 84904391148     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004;53(11):1566-70. (Pubitemid 39434095)
2. Wallace EA, Andrews SE, Garmany CL, Jelley MJ. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. South Med J 2011;104(9):659-64.
3. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012;87(2):114-9.
4. Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev 2011;4(4):241-9.
5. Sullivan S. Cannabinoid hyperemesis. Can J Gastroenterol 2010;24(5):284-5.
6. Hopkins CY, Gilchrist BL. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. J Emerg Med 2013;45(4):544-6. Epub 2013 Jul 26.
7. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997;74(2):129-80. (Pubitemid 27337346)
8. Pertwee RG. Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999;6(8):635-64. (Pubitemid 29399497)
9. Darmani NA. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta (9)-tetrahydrocannabinol and other cannabinoids. J Pharmacol Exp Ther 2002;300(1):34-42. (Pubitemid 34028505)
10. McCallum RW, Soykan I, Sridhar KR, Ricci DA, Lange RC, Plankey MW. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther 1999;13:77-80. (Pubitemid 29048059)
11. Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc 2009;84(1):76-8.
12. Gunasekaran N, Long LE, Dawson BL, Hansen GH, Richardson DP, Li KM, et al. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. Br J Pharmacol 2009;158(5):1330-7. Epub 2009 Aug 14.
13. Parker LA, Kwiatkowska M, Burton P, Mechoulam R. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology 2004;171(2):156-61. (Pubitemid 38134652)
14. Rock EM, Goodwin JM, Limebeer CL, Breuer A, Pertwee RG, Mechoulam R, et al. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology 2011;215(3):505-12. Epub 2011 Jan 18.
15. Patterson DA, Smith E, Monahan M, Medvecz A, Hagerty B, Krijger L, et al. Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation. J Am Board Fam Med 2010;23(6):790-3.
16. Nicolson SE, Denysenko L, Mulcare JL, Vito JP, Chabon B. Cannabinoid hyperemesis syndrome: a case series and review of previous reports. Psychosomatics 2012;53(3):212-9. Epub 2012 Apr 4.
17. Hickey JL, Witsil JC, Mycyk MB. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Am J Emerg Med 2013;31(6):1003.e5-6.
18. Cox B, Chhabra A, Adler M, Simmons J, Randlett D. Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use. Case Rep Med 2012;2012:757696.